Schedule 13G ownership disclosure

ESSA PHARMA INC

Security class unavailable · CUSIP: 29668H104

Event date: 2018-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
27,719,410
Percent of class
19.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001580642-18-001488
Form type
SC 13G/A
Filer
ESSA Pharma Inc.
CIK
CIK 1633932
Filed
Mar 09, 2018
Reporting period
Feb 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub